Last reviewed · How we verify

NCT03033979

Prolonged Laryngeal Mask Airway ProSealTM Use

Completed Last updated 27 January 2017
What this trial tests

trial in Airway Management in 7 participants. Completed in 31 December 2015.

Timeline
1 January 2015
Primary endpoint
31 December 2015
31 December 2015

Quick facts

Lead sponsorSchulthess Klinik
StatusCompleted
Study typeOBSERVATIONAL
Enrollment7
Start date1 January 2015
Primary completion31 December 2015
Estimated completion31 December 2015
Sites1 location across Switzerland

Conditions studied

Sponsor

Schulthess Klinik

Who can join

Adults 19 to 85, any sex, with Airway Management. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators conclude that use of the LMA ProSealTM for prolonged procedures is feasible. In principle, it should be safer and more effective than the LMA ClassicTM provided basic guidelines are followed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Airway Management

Currently open trials in the same condition.

Other Schulthess Klinik trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03033979.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing